Viewpoint Capital Management’s WisdomTree International SmallCap Dividend Fund DLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$507K Hold
6,221
0.24% 68
2025
Q4
$504K Hold
6,221
0.22% 68
2025
Q3
$495K Sell
6,221
-220
-3% -$17.1K 0.22% 66
2025
Q2
$484K Sell
6,441
-30
-0.5% -$2.1K 0.24% 68
2025
Q1
$427K Hold
6,471
0.23% 69
2024
Q4
$407K Hold
6,471
0.21% 69
2024
Q3
$446K Hold
6,471
0.25% 66
2024
Q2
$411K Hold
6,471
0.25% 67
2024
Q1
$422K Hold
6,471
0.27% 69
2023
Q4
$413K Hold
6,471
0.29% 63
2023
Q3
$372K Hold
6,471
0.3% 63
2023
Q2
$385K Hold
6,471
0.3% 65
2023
Q1
$394K Hold
6,471
0.35% 60
2022
Q4
$375K Hold
6,471
0.36% 58
2022
Q3
$333K Hold
6,471
0.33% 62
2022
Q2
$378K Hold
6,471
0.35% 59
2022
Q1
$444K Hold
6,471
0.34% 60
2021
Q4
$477K Buy
+6,471
New +$476K 0.35% 60

Other funds holding DLS

Viewpoint Capital Management's DLS Position: Q1 2026 in Review

Viewpoint Capital Management held its WisdomTree International SmallCap Dividend Fund (DLS) position steady in Q1 2026 at 6,221 shares worth $507K. The position accounts for 0.24% of the portfolio, ranked #68.

Viewpoint Capital Management first reported a position in DLS in Q4 2021 and has held it in 18 quarters since. 204 funds tracked by Wall St. Rank hold DLS as of Q1 2026.

  • Viewpoint Capital Management held 6,221 shares of WisdomTree International SmallCap Dividend Fund worth $507K as of Q1 2026.
  • Viewpoint Capital Management left its WisdomTree International SmallCap Dividend Fund share count unchanged in Q1 2026.
  • WisdomTree International SmallCap Dividend Fund made up 0.24% of Viewpoint Capital Management's portfolio in Q1 2026, its #68 holding.
  • Viewpoint Capital Management first reported a position in WisdomTree International SmallCap Dividend Fund in Q4 2021 and has held it in 18 quarters since.
  • 204 funds tracked by Wall St. Rank held WisdomTree International SmallCap Dividend Fund as of Q1 2026.

Based on Viewpoint Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.